July 2026
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated the impact of a text messaging intervention on patient-reported outcomes in individuals with Type 2 diabetes, finding significant improvements in various health-related measures.
Interventions
SMS text messaging behavioral intervention for health promotion
Outcomes
Diabetes knowledgeDiabetes management self-efficacyDiabetes self-management behaviors+6 more
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated a text messaging-based lifestyle support program for women with gestational diabetes. Results showed no significant differences in key health outcomes compared to a control group.
Interventions
Peer-support lifestyle program
Outcomes
BMIComposite of Weight, Physical Activity, and Dietary GoalsPhysical activity level (MET-minutes per week)+7 more
Added to Dediabetes Jul 12, 2026Non Randomized CT
The BRIDGE study evaluated a text messaging support program for postpartum care in women with impaired glucose tolerance, finding significant improvements in follow-up care.
Interventions
SMS text messaging behavioral intervention for health promotion
Outcomes
Completion of HbA1c testing by 1 year postpartumCompletion of HbA1c testing by 12 weeks postpartumPercentage of participants who scheduled a visit with a primary care provider by 12 weeks postpartum
Added to Dediabetes Jul 12, 2026RCTs
This study developed two automated texting systems aimed at improving diabetes self-management. Findings indicated that a significant portion of messages were rated as relevant and confidence-enhancing.
Outcomes
Confidence-enhancing message ratingCustomization preference for message frequencyMessage relevance rating+1 more
Added to Dediabetes Jul 12, 2026RCTs
The study evaluated a three-tiered linkage management model for T2DM, finding significant improvements in glycemic control and self-management.
Interventions
Structured multidisciplinary case management
Outcomes
Diabetes self-management behaviorsFasting Plasma Glucose (FPG)HbA1c+1 more
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated ticagrelor monotherapy after 3 months of dual antiplatelet therapy in diabetic patients with acute coronary syndrome, finding no significant difference in major adverse cardiovascular events.
Interventions
AspirinTicagrelor monotherapy after 3 months of DAPT
Outcomes
Bleeding eventsComposite cardiovascular events (CV death, MI, stroke, HF hospitalization)
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated the impact of tighter glycaemic control in women with gestational diabetes. It found a reduction in serious health outcomes for infants but an increase in serious maternal health outcomes.
Interventions
Less tight glycemic controlTighter glycemic control
Outcomes
Composite cardiovascular events (CV death, MI, stroke, HF hospitalization)Serious maternal health outcomeSerious perinatal adverse events
Added to Dediabetes Jul 12, 2026RCTs
This study examined the effects of time-restricted eating on sleep in adults with type 2 diabetes and found no significant impact on sleep quality or duration.
Interventions
Calorie restrictionTime-Restricted Eating (TRE)
Outcomes
Deep sleep duration (SWS)Insomnia SeverityRisk of Obstructive Sleep Apnoea (OSA)+1 more
Added to Dediabetes Jul 12, 2026RCTs
This study compared tirzepatide and dulaglutide in improving insulin sensitivity and beta-cell function in adults with type 2 diabetes, finding tirzepatide more effective.
Interventions
DulaglutideTirzepatide
Outcomes
AdiponectinFasting insulin levelsHomeostatic model assessment (HOMA2-B)+4 more
Added to Dediabetes Jul 12, 2026RCTs
Tirzepatide treatment significantly improved cardiometabolic risk factors in adults with obesity or overweight.
Outcomes
BMIBody weightDiastolic blood pressure+6 more